Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients
Open Access
- 1 October 1999
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (4) , 688-693
- https://doi.org/10.1016/s0272-6386(99)70394-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicityAmerican Journal of Kidney Diseases, 1995
- Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patientsKidney International, 1992
- Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre StudyNephrology Dialysis Transplantation, 1990
- Aluminum-associated bone disease in chronic renal failure: High prevalence in a long-term dialysis populationJournal of Bone and Mineral Research, 1986
- Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.BMJ, 1985
- Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related OsteodystrophyAnnals of Internal Medicine, 1984
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY: An Epidemiological SurveyPublished by Elsevier ,1979
- The Dialysis Encephalopathy SyndromeNew England Journal of Medicine, 1976
- Quantitative Histological Studies on the Pathogenesis of Uremic Bone Disease*Journal of Clinical Endocrinology & Metabolism, 1974